Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)
Clinical trial NCT00255008 · TERMINATED
Trial details
- NCT number
- NCT00255008
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2007-12-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.